TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

Current Location: HOME >> Product
Product Categories
Country: China
Tel:
Mobile: 15002134094
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
LY88074 Methyl ether C22H16O4S 63675-88-7 Details
LY3020371 hydrochloride C15 H15 F2 N O5 S . Cl H 1377615-44-5 Details
LSD1-IN-6 C15H13BrN2O3 2035912-43-5 Details
LY 541850 C9H13NO4 852679-76-6 Details
Lamivudine 13C,15N2 C8H9N3O4S 1391052-30-4 Details
LSD1-IN-5 C15H13BrN2O3 2035912-55-9 Details
KRAS inhibitor-7 C26H27ClF2N6O2 2022986-68-9 Details
KRAS G12C inhibitor 14 C24H19ClF2N4O3 2349393-95-7 Details
KRN2 C27H23ClFNO4 248260-75-5 Details
KRAS inhibitor-8 C26H24ClF4N5O3 2022986-70-3 Details
β3-AR agonist 2 C27H38N4O7S 340757-05-3 Details
Kv3 modulator 4 C20H24N2O4 2173375-10-3 Details
KRAS inhibitor-6 C27H30ClF2N5O3 2022986-61-2 Details
L-692429 C29H31N7O2 145455-23-8 Details
HDAC-IN-5 C26H24F3N5O2S 1314890-51-1 Details
JAK-IN-5 hydrochloride C27H32ClFN6O 2751323-21-2 Details
JAK-IN-1 C20H24N6O2 1334673-53-8 Details
GYKI 52466 dihydrochloride C17H16ClN3O2 2319722-40-0 Details
HG-12-6 C29H27F3N6O2S 2222354-57-4 Details
IL-17A antagonist 3 C33H33ClN6O4 2230780-65-9 Details
JAK-IN-3 C18H20N4O3 1400876-94-9 Details
HIV-1 integrase inhibitor 7 C30H26O16 204268-03-1 Details
IACS-8779 C21H25N9O10P2S2 2243079-26-5 Details
HPN-01 C19H16ClN3O3S 928655-63-4 Details
Indirubin-5-sulfonate C16H10N2O5S 244021-67-8 Details
GW768505A free base C27H19F4N5O3 501693-25-0 Details
KD-3010 C30H33F3N2O8S2 934760-92-6 Details
KDOAM-25 citrate C15H25N5O2.C6H8O7 2448475-08-7 Details
H3B-6545 Hydrochloride C30H30ClF4N5O2 2052132-51-9 Details
HMG499 C33H54O3 2416941-68-7 Details
GPR120 Agonist 1 C20H12ClF6NO3S 1628448-77-0 Details
DHODH-IN-13 C10H6F3N3O3 1364791-86-5 Details
hDHODH-IN-5 C21H21F3N2O2 2029049-77-0 Details
Derazantinib Racemate C29H29FN4O 2309668-44-6 Details
GC 14 C26H27NO6 447415-34-1 Details
DDR-TRK-1 C26H23F3N6O 1934246-19-1 Details
EGFR-IN-2 C26H33N9O3S 1643497-70-4 Details
GKI-1 C15H12ClN3 2444764-03-6 Details
Frakefamide C30H34FN5O5 188196-22-7 Details
Etamicastat hydrochloride C14H16ClF2N3OS 677773-32-9 Details
Endothelial lipase inhibitor-1 C22H22N4O4 1466427-02-0 Details
DHODH-IN-14 C15H7F4N3O3 1364791-93-4 Details
DHODH-IN-8 C17H13ClN2O2 1148126-03-7 Details
G6PD activator AG1 C24H30N4S2 421581-52-4 Details
FGI-106 C28H38N6 501081-38-5 Details
GSK1521498 C24H23F2N4O4P 1426543-84-1 Details
DYRKs-IN-1 C30H30ClN7O4 1387090-01-8 Details
Foliglurax C23H23N3O3S 1883329-51-8 Details
GlyT1 Inhibitor 1 C22H21N5O2 1820934-93-7 Details
CYP17-IN-1 C18H17FN2S 2093317-51-0 Details
DB1976 dihydrochloride C20H17ClN8Se 2369663-93-2 Details
DSP-0565 C14H12FNO 1226855-28-2 Details
DHODH-IN-15 C15H11N3O3 1364791-88-7 Details
DC_C66 C28H22NO2+ 108181-00-6 Details
GSK1521498 free base C24H20F2N4 1007573-18-3 Details
EG01377 C26H30N6O6S2 2227996-00-9 Details
DSP-1053 C26H32BrNO4 1176326-76-3 Details
GSK3004774 C32H40N4O3 2138814-32-9 Details
EMT inhibitor-2 C24H26N2O8 2232228-60-1 Details
GABAB receptor antagonist 1 C18H24O4 797-17-1 Details
GF 15 C23H21ClO6 888042-13-5 Details
FAK inhibitor 5 C20H21N3O2S 1426683-30-8 Details
BMY-43748 C20H17F3N4O3 132195-65-4 Details
CXCR7 modulator 2 C29H42N6O3 2227426-37-9 Details
CDK4/6/1 Inhibitor C28H30F2N6 2099128-41-1 Details
CB2 modulator 1 C18H19F3N4O2 666261-80-9 Details
BAY-784 C29H26ClF4N3O5S2 1631164-24-3 Details
c-Met-IN-2 C24H21FN10O 1635406-73-3 Details
BLM-IN-1 C28H35FN4O 2056014-40-3 Details
CDK4/6-IN-3 C25H31FN8 2366237-37-6 Details
c-Fms-IN-9 C21H23N7O2 1628574-50-4 Details
CRT0066854 hydrochloride C24H26ClN5S 2250019-91-9 Details
CP-060 C30H42N2O5S 180090-15-7 Details
Asthma relating compound 1 C17H19N3O3S2 120165-51-7 Details
CRTH2-IN-1 C21H21FN2O4S 926661-54-3 Details
AZ12601011 C19H15N5 2748337-86-0 Details
β-NF-JQ1 C45H42ClN5O6S 2380000-55-3 Details
β3-AR agonist 1 C22H28N4O4S 1283125-73-4 Details
BRL-42715 C10H9N4NaO3S 102209-75-6 Details
CK2/PIM1-IN-1 C15H9NO4S2 292640-28-9 Details
CBP/p300-IN-2 C27H29F2N7O2 2158265-96-2 Details
AR453588 C25H25N7O2S2 1065609-00-8 Details
c-Kit-IN-2 C25H29N9O2S 2121515-37-3 Details
CT-721 C30H29ClN6O 1388710-60-8 Details
BPH-652 C16H16K3O7PS 157124-84-0 Details
Chalcone 4 hydrate C16H15ClO4 1202866-96-3 Details
Ciraparantag acetate C24H52N12O4 1644388-83-9 Details
CFTR corrector 4 C29H27F2NO7 1918142-34-3 Details
COH34 analog 1 C18H15NO3S 314248-24-3 Details
BMS-654457 C36H37N5O4 1004551-41-0 Details
Closthioamide C29H38N6O2S6 1227367-59-0 Details
Cyclophilin inhibitor 1 C31H39N5O7 1509904-96-4 Details
BIIL-260 hydrochloride C30H31ClN2O3 192581-24-1 Details
BRD5631 C30H35N3O4 2446154-91-0 Details
A 83-01 sodium salt C25H20N5NaS 2828431-89-4 Details
BACE1-IN-4 C21H23F2N5O4S2 2361157-92-6 Details
CCR1 antagonist 6 C21H23ClN4O3S 2436773-01-0 Details
S1PR1-MO-1 C25H29N3O3 1149727-61-6 Details
CCR7 Ligand 1 C22H29N5O5S 681514-83-0 Details
BPN-15606 C23H23FN6O 1914989-49-3 Details
Product Total: Product Page:
68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188